跳至主要内容
临床试验/TCTR20220118001
TCTR20220118001招募中4 期

The effect of Roux-en-Y Gastric Bypass surgery in morbidly obese patients on pharmacokinetic of lansoprazole

Ratchadapisek Sompoch Endowment Fund Chulalongkorn university0 个研究点目标入组 16 人开始时间: 2022年1月18日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
16

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 0 N/A (No limit)(—)
性别
All

入选标准

  • The target population is obese patients admitted to Chulalongkorn Hospital which have indications for surgery according to National Institute of Health (NIH) guidelines that are BMI> 40 kg / m2 or BMI> 35 kg / m2 and also have associated diseases such as diabetes, hypertension, coronary heart disease, sleep apnea, age over 18 years old and associated with peptic ulcers.

排除标准

  • Patients with exclusion criteria are patients who had previously undergone bariatric surgery, unable to swallow drugs, taking statins for the dyslipidemia treatment, and in patients who is allergic to lansoprazole and or taking drug interacted with lansoprazole: Acalabrutinib, Atazanavir, Cilostazol, Citalopram, Dacomitinib, Dasatinib, Erlotinib, Methotrexate, Nelfinavir, Neratinib, Pazopanib, Pexidartinib, Rilpivirine, Tacrolimus

研究者

发起方
Ratchadapisek Sompoch Endowment Fund Chulalongkorn university

相似试验

The effect of Roux-en-Y Gastric Bypass surgery in... | 临床试验